LoadingLoadingLoadingNet selling: insiders sold $3.2M and bought $851K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Sells/Trims (1)
Sachem Head
$34.5M
sold
No tracked top-trader positions in CXM as of Oct 21, 17:16 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Sep 2, 2026
Period ending
Jul 31, 2026
Earnings per share
$0.10 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jul 31, 2026 | Sep 2, 2026 | $0.11 / $0.10Yahoo Finance | +5.25% beat | $213.7M No estimate | Unavailable |
| Apr 30, 2026 | Jun 3, 2026 | $0.11 / $0.10Yahoo Finance | +$0.01 beat | $219.5M No estimate | Unavailable |
| Jan 31, 2026 | Mar 11, 2026 | $0.13 / $0.10Yahoo Finance | +$0.03 beat | $220.6M No estimate | Unavailable |
| Oct 31, 2025 | Dec 3, 2025 | $0.12 / $0.09Yahoo Finance | +$0.03 beat | $219.1M No estimate | Unavailable |
| Jul 31, 2025 | Sep 3, 2025 | $0.13 / $0.10Alpha Vantage | +30.00% beat | $212.0M No estimate | Unavailable |
| Apr 30, 2025 | Jun 4, 2025 | $0.12 / $0.10Alpha Vantage | +20.00% beat | $205.5M No estimate | Unavailable |
| Jan 31, 2025 | Mar 12, 2025 | $0.04 / $0.02Alpha Vantage | +$0.02 beat | $202.5M No estimate | Unavailable |
| Oct 31, 2024 | Dec 4, 2024 | $0.10 / $0.08Alpha Vantage | +$0.02 beat | $200.7M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Oct 2025 | Jan 2026 | Apr 2026 | Jul 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $219.1M | $220.6M | $219.5M | $213.7M |
| Cost of what it sold | $73.6M | $75.8M | $76.4M | $74.6M |
| Gross profit | $145.5M | $144.8M | $143.0M | $139.2M |
| What it spent | ||||
| Research and development | $24.7M | $25.3M | $23.4M | $24.4M |
| Sales and admin | $33.7M | $33.4M | $34.8M | $34.3M |
| Other operating costs | $75.0M | $71.0M | $74.9M | $70.9M |
| Total operating expenses | $133.4M | $129.7M | $133.1M | $129.7M |
| What was left | ||||
| Operating profit | $12.3M | $15.4M | $10.0M | $9.5M |
| Profit before tax | $17.3M | $20.6M | $16.3M | $12.7M |
| Tax | $14.4M | $11.6M | $12.1M | $5.6M |
| Net profit | $2.9M | $9.0M | $4.2M | $7.1M |
| EBITDA | $17.1M | $20.3M | $14.2M | $14.4M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
11 macro signals shaping CXM right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
